Potential Role of the Endocannabinoid Receptor Antagonist Rimonabant in the Management of Cardiometabolic Risk: A Narrative Review of Available Data
Vascular Health and Risk Management - New Zealand
doi 10.2147/vhrm.2007.3.2.181
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2007
Authors
Publisher
Informa UK Limited